Lili Mao

机构：Shanghai University of Sport, Peking University, Peking University Cancer Hospital, Ministry of Education

发表论文 21 篇 · 总被引 119 次 · h-index 6

代表论文

• Oncolytic virus OH2 extends survival in patients with PD-1 pretreated melanoma: phase Ia/Ib trial results and biomarker insights (2025 · Journal for ImmunoTherapy of Cancer · 被引 22)
• Clinicopathological Significance of PTEN and Caspase-3 Expressions in Breast Cancer (2008 · 中国医学科学杂志：英文版 · 被引 20)
• Efficacy and safety of DV in HER2-negative and HER2-low locally advanced or metastatic urothelial carcinoma: Results of a phase 2 study (2025 · Med · 被引 16)
• Expert consensus on the diagnosis and treatment of solid tumors with BRAF mutations (2024 · The Innovation · 被引 14)
• A phase 2 clinical trial of neoadjuvant anti-PD-1 ab (Toripalimab) plus axitinib in resectable mucosal melanoma. (2021 · Journal of Clinical Oncology · 被引 11)
• Palbociclib (P) in advanced acral lentiginous melanoma (ALM) with CDK4 pathway gene aberrations. (2019 · Journal of Clinical Oncology · 被引 8)